StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Provectus Biopharmaceuticals's market cap was $20.55M on Oct 19, 2026, against $30.25M a year earlier. Over the last 5 years it ranged from $19.75M to $83.07M, with a median of $36.75M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$20.55M-12.5%
2025Dec 31, 2025$23.49M-53.5%
2024Dec 31, 2024$50.48M+25.3%
2023Dec 29, 2023$40.27M-11.1%
2022Dec 30, 2022$45.31M+96.4%
2021Dec 31, 2021$23.07M+0.2%
2020Dec 31, 2020$23.02M-6.0%
2019Dec 31, 2019$24.48M+27.7%
2018Dec 31, 2018$19.18M-36.9%
2017Dec 29, 2017$30.40M+523.2%
2016Dec 30, 2016$4.88M-93.9%
2015Dec 31, 2015$79.81M-44.7%
2014Dec 31, 2014$144.24M-57.2%
2013Dec 31, 2013$337.34M+444.7%
2012Dec 31, 2012$61.93M-30.3%
2011Dec 30, 2011$88.81M–

More Provectus Biopharmaceuticals figures

See a number that looks wrong?